Additionally, melatonin has been shown to modulate PXR, which downregulates Glut2 and contributes to glucose intolerance [37,38], raising the possibility that melatonin’s effects are mediated in part through PXR inhibition. The gene discussed is NR1I2; the disease is Glucose intolerance.